Amneal seeks $1.8B new term loans and $750M notes to refinance debt

Amneal Pharmaceuticals, Inc.

Amneal subsidiary seeks $1.8B in new seven-year term B loans to refinance existing term loans.
Launching $750M private offering of senior secured notes due 2032.
Proceeds to repay existing term B loans in full and a portion of ABL borrowings.
Notes offering not conditioned on the new term loan facility.
Transactions subject to market conditions; no assurance of completion or final terms.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.